With GLP-1 therapies growing in popularity, there’s no better time to get a deeper understanding of how they’ll affect Type 2 diabetes and obesity care. Don’t miss our upcoming webinar to learn about the opportunities and challenges of this new class of drugs for the Type 2 diabesity epidemic: https://lnkd.in/gEHKFxEk #ChronicCare #Diabetes #Webinar
